| 000 | 01757 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511225631.0 | ||
| 264 | 0 | _c19900629 | |
| 008 | 199006s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199006000-00010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCocconi, G | |
| 245 | 0 | 0 |
_aNeoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma. A prospective, randomized study. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cJun 1990 |
||
| 300 |
_a226-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xanalysis |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _adi Blasio, B | |
| 700 | 1 | _aBisagni, G | |
| 700 | 1 | _aAlberti, G | |
| 700 | 1 | _aBotti, E | |
| 700 | 1 | _aAnghinoni, E | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 13 _gno. 3 _gp. 226-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199006000-00010 _zAvailable from publisher's website |
| 999 |
_c2195414 _d2195414 |
||